Latest News


Neuroscience and Pain Research

New approach delivers breakthrough for pain researchers.

Researchers at the Kolling Institute have made important progress towards the development of new treatments for chronic pain by identifying a small group of cells which can control pain responses. The breakthrough comes as approximately 20 per cent of the world’s population suffers from chronic pain, including around 3.4 million Australians. Dr Neda Assareh, a neuroscientist research fellow from th.....
Read more

Category: Neuroscience and Pain Research, Research Excellence

World leading Meniere’s disease expert joins the Kolling.

In a sign of the growing neuroscience expertise at the Kolling Institute, internationally recognised Meniere’s disease expert Professor Jose Antonio Lopez Escamez has relocated from Spain to the institute. Professor Lopez Escamez has launched an exciting new international research program into the disease, extending his body of work in Europe. Meniere’s disease is a rare disease of the inner ear th.....
Read more

Category: Neuroscience and Pain Research, Research Excellence

Kolling awards unveiled.

We are pleased to announce the successful recipients of our annual Kolling Institute awards program. Launched in 2021, the program has been expanded to acknowledge a greater number of researchers and their individual contribution to the Kolling. The awards aim to recognise the many outstanding achievements across education, clinical practice and service, publications, research, as well as overall a.....
Read more

Category: Awards, Cardiovascular and Renal Research, Musculoskeletal Research, Neuroscience and Pain Research

Study finds multiple medications impact how we age and the health of our gut.

A new study by researchers at the Kolling Institute, in collaboration with the Microbiome Research Centre, has shown that multiple medication use impacts gut microbiome, and may influence the ageing process. Gizem Gemikonakli, a PhD student at the University of Sydney, said their findings followed a longitudinal, in vivo study. “Interestingly, mice that were given a regimen of five therapeutic medi.....
Read more

Category: Neuroscience and Pain Research, Research Excellence

Innovative trial aims to reduce the impact of serious spinal cord injuries.

A simple yet smart approach may hold the key to greatly improved health for those with life-changing spinal cord injuries. Researchers from the Kolling Institute’s John Walsh Centre for Rehabilitation Research are launching a project to assess whether a specific breathing technique can improve many of the challenges faced by people with a spinal cord injury, like chronic pain, life threatening unst.....
Read more

Category: Neuroscience and Pain Research, Research Excellence

Researchers closer to better pain management strategies.

Researchers at the Kolling Institute have taken an important step towards the development of safer, non-addictive pain medications by increasing our understanding of spinal cord pain signalling. This valuable progress has been recognised internationally with publication in the Journal of Physiology, a leading scientific journal. The findings follow the latest figures indicating more than 20 per cen.....
Read more

Category: Neuroscience and Pain Research, Research Excellence

Innovative research on show.

An impressive group of emerging leaders addressed the Kolling’s Neuroscience and Pain Showcase, sharing details of their diverse and exciting research projects. With a broad range of expertise in this field, the showcase involved representatives from the pain management and rehabilitations teams, as well as the ageing, mental health, neurogenetics and neuromuscular imaging groups. The early and mid.....
Read more

Category: Neuroscience and Pain Research, Research Excellence

Back pain treatments shouldn’t neglect the mind.

New research by a team from the Kolling Institute has found the best treatment for chronic low back pain doesn’t just focus on the physical, but combines physiotherapy treatments with those focusing on the mind. The study, involving Emma Ho, Professor Manuela Ferreira and Lingxiao Chen, analysed evidence from almost 100 trials worldwide involving over 13,000 patients. It found a combination of phys.....
Read more

Category: Musculoskeletal Research, Neuroscience and Pain Research, Research Excellence

Australia to introduce ground breaking technology to target debilitating Mito disease.

Clinicians, researchers and patients have welcomed a landmark law which will pave the way for remarkable new IVF technology to prevent mitochondrial disease. Known as “Maeve’s law” after a young Victorian girl with a rare genetic disorder, the legislation was passed by Federal Parliament allowing the specialised IVF procedure to be carried out in Australia. It will involve replacing faulty mitochon.....
Read more

Category: Neuroscience and Pain Research, New Treatment, World-leading technology

Researchers identify the best way to ease chronic pain.

With large numbers of people across the community looking for effective and lasting ways to treat pain, our researchers at the Kolling Institute are driving nationally significant projects to reduce a reliance on opioid medication and promote proven alternative options. The research by our team from the Pain Management Research Centre follows the latest figures which indicate around 20 per cent of .....
Read more

Category: Neuroscience and Pain Research, New Treatment, Research Excellence